Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism γ-secretase modulators(Gamma-secretase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H21F6N7O2 |
InChIKeyPPZKUFDGGKRNJA-BTABJRDXSA-N |
CAS Registry2101533-11-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | CH | 13 Aug 2020 |